Lenalidomide
Lenalidomide (initially known as CC-5013 and marketed as Revlimid? by Celgene) is a derivative of thalidomide introduced in 2004.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
259.26
Molecular Formula
C13H13N3O3
Notes
Research use only, not for human use.
Receptor
TNF-α
CAS Number
191732-72-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TL309563V 500 µL Each
CD162 (SELPLG) Human shRNA Lentiviral Particle (Locus ID 6404)
Ask
View Details